U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: over 10,000 records

Showing results for "condition".

  1. Chipra-141-Section-2-Tech-Specs (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-141-section-2-tech-specs.pdf
    December 01, 2012 - 'Complex' and 'Non-Complex' designations are assigned based on whether a child's condition(s) … , c) indication if a progressive condition, and d) indication if malignancy … Final Condition Definitions: This program calculates two separate variables containing condition … one body system is indicated in more than one claim, and 2) the condition … DETERMINATION--calculate condition type based on two different algorithms **************************

  2. Chipra-141-Section-2-Tech-Specs (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-141-section-2-tech-specs.pdf
    December 01, 2012 - 'Complex' and 'Non-Complex' designations are assigned based on whether a child's condition(s) … , c) indication if a progressive condition, and d) indication if malignancy … Final Condition Definitions: This program calculates two separate variables containing condition … one body system is indicated in more than one claim, and 2) the condition … DETERMINATION--calculate condition type based on two different algorithms **************************

  3. Chipra-141-Section-2-Tech-Specs (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-141-section-2-tech-specs.pdf
    December 01, 2012 - 'Complex' and 'Non-Complex' designations are assigned based on whether a child's condition(s) … , c) indication if a progressive condition, and d) indication if malignancy … Final Condition Definitions: This program calculates two separate variables containing condition … one body system is indicated in more than one claim, and 2) the condition … DETERMINATION--calculate condition type based on two different algorithms **************************

  4. U.S. Preventive Services Task Force Recommends Low-Dose Aspirin for Women at High Risk for Preeclampsia (pdf file)

    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/asprpregfinalrsbulletin.pdf
    September 09, 2014 - risk for preeclampsia use low-dose aspirin (81 mg/day) after 12 weeks of pregnancy to prevent the condition … to pregnant women who are at high risk for preeclampsia, who do not show signs or symptoms of the condition … Preeclampsia is a complex condition that occurs in pregnant women and is characterized by a rise in … at high risk for developing preeclampsia can take a low daily dose of aspirin to help prevent the condition

  5. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  6. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  7. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  8. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  9. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  10. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  11. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  12. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  13. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  14. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  15. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  16. DSF Measures 2-3 Attachment 11.1 (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  17. DSF Measures 2-3 Attachment 11.1 (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  18. DSF Measures 2-3 Attachment 11.1 (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_XIA.pdf
    February 29, 2016 - V71.02 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … V80.0 Special screening for neurologic condition 32. … Z03.89 Observation for suspected mental condition; childhood or adolescent antisocial behavior 27. … Z13.858 Special screening for neurologic condition 32. Z13.88 Special screening for lead poisoning

  19. U.S. Preventive Services Task Force Recommends Screening All Pregnant Women for Gestational Diabetes in Final Statement (pdf file)

    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/gdmbulletin.pdf
    January 14, 2014 - The condition is on the rise as obesity, older age during pregnancy, and other risk factors become more … for gestational diabetes after 24 weeks of pregnancy in all women who do not have symptoms of the condition … Preeclampsia is a condition in pregnant women characterized by high blood pressure and high levels of … diabetes during pregnancy can also prevent babies from growing larger than normal (macrosomia), a condition

  20. U.S. Preventive Services Task Force Issues Draft Statement: Screening for Hypertension in Children and Adolescents (pdf file)

    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/hypechlddraftbulletin.pdf
    February 26, 2013 - high blood pressure because it is difficult to predict which children and teens will develop the condition … health problem, there is not enough solid evidence to recommend that they should be screened for the condition … Secondary hypertension is usually caused by an underlying condition that is generally accompanied by … treatment of secondary hypertension is likely to be handled as part of the management of the underlying condition
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

ecareplan.ahrq.gov (15821)

cmext.ahrq.gov (7900)

www.ahrq.gov (5708)

psnet.ahrq.gov (4618)

hcup-us.ahrq.gov (3465)

ce.effectivehealthcare.ahrq.gov (3388)

digital.ahrq.gov (3078)

effectivehealthcare-admin.ahrq.gov (2441)

effectivehealthcare.ahrq.gov (2336)

www.qualitymeasures.ahrq.gov (2054)

www.uspreventiveservicestaskforce.org (1555)

www.talkingquality.ahrq.gov (1255)

www.monahrq.ahrq.gov (1236)

www.innovations.ahrq.gov (1233)

www.healthcare411.ahrq.gov (1226)

www.cahps.ahrq.gov (1173)

meps.ahrq.gov (1062)

www.cpsi.ahrq.gov (1058)

cahps.ahrq.gov (957)

healthcare411.ahrq.gov (954)

monahrq.ahrq.gov (946)

pbrn.ahrq.gov (888)

pcmh.ahrq.gov (884)

talkingquality.ahrq.gov (832)

patientregistry.ahrq.gov (806)

ahrqpubs.ahrq.gov (779)

preventiveservices.ahrq.gov (653)

teamstepps.ahrq.gov (560)

srdr.ahrq.gov (213)

cds.ahrq.gov (195)

qualityindicators.ahrq.gov (165)

nhqrnet.ahrq.gov (128)

datatools.ahrq.gov (68)

staging-meps.ahrq.gov (67)

cdsic.ahrq.gov (48)

www.psoppc.org (48)

info.ahrq.gov (26)

srdrplus.ahrq.gov (23)

cahpsdatabase.ahrq.gov (17)

pso.ahrq.gov (13)

covid-acts.ahrq.gov (8)

hcupnet.ahrq.gov (2)

www.distributor.hcup-us.ahrq.gov (2)

jamanetwork.com (1)